Chemical Structure (Morphine Sulfate Ir 1)
Morphine Sulfate Tablet
Product Images NDC 67296-2122
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Morphine Sulfate (NDC 67296-2122). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Redpharm Drug, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Principal Display Panel (15 mg Bottle)
This is a description for a medication containing Morphine Sulfate in tablet form. Each tablet contains 15 mg of Morphine Sulfate USP equivalent to 12.5 mg of Morphine base. The usual dosage can be found in the package insert provided. It is recommended to store the medication at room temperature between 20-25°C and protect it from moisture. The medication should be dispensed in a tight, light-resistant container. It is important to keep this and all medications out of reach of children. The manufacturer is SpecGx LLC located in Webster Groves, MO, USA.*
Principal Display Panel (30 mg Bottle)
This text provides information about a medication, specifically Morphine Sulfate tablets containing 30mg of Morphine Sulfate USP equivalent to 23.3mg Morphine base. The usual dosage instructions are provided on the package. It also includes guidelines on storage conditions (below 25°C) and highlights the importance of keeping the medication away from children. The manufacturer is SpecGx LLC located in Webster Groves, MO, USA.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
